Lorenzo Gasperoni

10PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsToxicology (incl. clinical toxicology)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data.

|Jun 26, 2026
Comparative Efficacy of First-Line Therapeutic Options for ES-SCLC: An Indirect Comparison Using IPDfromKM-Reconstructed Individual Patient Data.

|Jun 15, 2026
Long-term outcomes of ALK inhibitors in metastatic <i>ALK</i>-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data.

|Nov 27, 2025
Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based Regimens.

Lorenzo Gasperoni, Luca Cancanelli, Andrea Ossato

|Jan 24, 2025
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trials.

Andrea Messori, Andrea Ossato, Lorenzo Gasperoni

|Jul 13, 2024
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy?

Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato

Pageof 2

Frequent Collaborators

5 joint publications

Andrea Ossato

5 joint publications

Andrea Messori

3 joint publications

Luna Del Bono

2 joint publications

Emilio Francesco Giunta